ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma

Zhang, Nan; Zhang, Hao; Wu, Wantao; Zhou, Ran; Li, Shuyu; Wang, Zeyu; Dai, Ziyu; Zhang, Liyang; Liu, Fangkun; Liu, Zaoqu; Zhang, Jian; Luo, Peng; Liu, Zhixiong*; Cheng, Quan*华中科技大学; 南方医科大学; 哈尔滨医科大学
2022DOI: 10.7150/thno.74281
49被引6阅读
引用收藏
分享

摘要

Rationale: Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs) involved in the regulation of the immune system and displayed a cell-type-specific pattern in immune cell subsets. Given the vital role of tumor-infiltrating lymphocytes in effective immunotherapy, we explored the tumor-infiltrating immune cell-associated lncRNA (TIIClncRNA) in low-grade glioma (LGG), which has never been uncovered yet. @@@ Methods: This study utilized a novel computational framework and 10 machine learning algorithms (101 combinations) to screen out TIIClncRNAs by integratively analyzing the sequencing data of purified immune cells, LGG cell lines, and bulk LGG tissues. @@@ Results: The established TIICInc signature based on the 16 most potent TIIClncRNAs could predict outcomes in public datasets and the Xiangya in-house dataset with decent efficiency and showed better performance when compared with 95 published signatures. The TIIClnc signature was strongly correlated to immune characteristics, including microsatellite instability, tumor mutation burden, and interferon gamma, and exhibited a more active immunologic process. Furthermore, the TIIClnc signature predicted superior immunotherapy response in multiple datasets across cancer types. Notably, the positive correlation between the TIIClnc signature and CD8, PD-1, and PD-L1 was verified in the Xiangya in-house dataset. @@@ Conclusions: The TIIClnc signature enabled a more precise selection of the LGG population who were potential beneficiaries of immunotherapy.

学科与关键词

关键词
Immunotherapylow-grade gliomalncRNAimmune checkpointimmune infiltration
相关
加载中…
  • Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response
    Wang, Nan; Gao, Xin; Ji, Hang; Ma, Shuai; Wu, Jiasheng; Dong, Jiawei; Wang, Fang; Zhao, Hongtao; Liu, Zhihui; Yan, Xiuwei; Li, Bo; Du, Jianyang*; Zhang, Jiheng*; Hu, Shaoshan*Frontiers in Molecular Biosciences, 2022, 9: 942966.
  • Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy
    Ma, Jianli; Zhang, Minghui; Yu, Jinming*Frontiers in Oncology, 2022, 12: 899925.被引 5
  • A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response
    Duan, Wei-Wei; Yang, Li-Ting; Liu, Jian; Dai, Zi-Yu; Wang, Ze-Yu; Zhang, Hao; Zhang, Xun; Liang, Xi-Song; Luo, Peng; Zhang, Jian; Liu, Zao-Qu; Zhang, Nan; Mo, Hao-Yang; Qu, Chun-Run; Xia, Zhi-Wei*; Cheng, Quan*CNS Neuroscience & Therapeutics, 2023.
查看全部 →

发表信息

论文状态
公开发表
发表日期
2022
卷期
第 12 卷, 第 13 期
页码
5931-5948
DOI
10.7150/thno.74281
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82073893, 82172685, 81873635]; Hunan Provincial Natural Science Foundation of China [2022JJ20095]; Hunan Provincial Health Committee Foundation of China [202204044869]

作者

  • Z

    Zhang, Nan (第一作者)

    harbin med univ

  • Z

    Zhang, Hao

    2 · chongqing med univ

查看全部 14 位作者收起作者
  • W

    Wu, Wantao

  • Z

    Zhou, Ran

  • L

    Li, Shuyu

    huazhong univ sci & technol

  • W

    Wang, Zeyu

  • D

    Dai, Ziyu

  • Z

    Zhang, Liyang

  • L

    Liu, Fangkun

  • L

    Liu, Zaoqu

  • Z

    Zhang, Jian

    southern med univ

  • L

    Luo, Peng

    southern med univ

  • L

    Liu, Zhixiong (通讯)

  • C

    Cheng, Quan (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417